Updated

U.S. regulators approved a generic version of the HIV-prevention drug lenacapavir on November 2, 2026, for sale in low-income countries. PBS NewsHour reported that demand for the drug is far outstripping supply in Uganda, other parts of Africa and around the world, making it difficult to find. The drug is showing promising early signs, but access remains the central obstacle as the generic version becomes available.